Synogen invests in and partners with early-stage medical technology companies, providing them with assistance in vital areas such as management, business plan development, strategic planning, marketing, and regulatory and intellectual property issues. Our goal is to complement the company's existing team and to speed up the development of their technology. We help them create their business plan and execute on that plan. We provide the resources necessary for the company to further develop its technologies and execute on its business plan while still in its formative stages, increasing the value of the company as it moves to the next round of capital investment and increasing its chances of ultimate success.

We are true partners in our portfolio companies, taking an equity position as co-founders of the company. This allows the companies in which we invest to conserve scarce cash resources and invest those resources in profitable development efforts. It also provides us with the same basis for return on investment as the original founders and later stage venture capital investors. The company must succeed in order for us to earn a return on our investment. This principle aligns our incentives and gives us commonality of goals.